LONG DUC TRAN

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology DALLAS, TX NPI 1306895024

General Payments — all program years on this page

$2,691.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 141
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $295.95 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $295.9514

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $614.8435
2019 $650.3934
2020 $141.388
2021 $68.514
2022 $363.4018
2023 $556.6028
2024 $295.9514

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086214813 Bayer Healthcare Pharmaceuticals Inc. $20.32 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104625724 AstraZeneca Pharmaceuticals LP $21.51 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105401953 AstraZeneca Pharmaceuticals LP $19.88 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111727371 Amgen Inc. $26.69 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112850470 OPKO Pharmaceuticals, LLC $14.23 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116586165 GlaxoSmithKline, LLC. $22.15 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116601375 GlaxoSmithKline, LLC. $18.27 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117401466 Amgen Inc. $29.14 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117958130 Boehringer Ingelheim Pharmaceuticals, Inc. $16.03 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137688870 Takeda Pharmaceuticals U.S.A., Inc. $21.23 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149616634 Smith+Nephew, Inc. $14.77 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149875483 Travere Therapeutics, Inc. $30.12 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150693529 Aurinia Pharma U.S., Inc. $18.39 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150693531 Aurinia Pharma U.S., Inc. $23.22 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.